Abstract
BACKGROUND: Dystonia patients undergoing deep brain stimulation (DBS) often require individualized stimulation settings. While effective settings reduce dystonia, excessive stimulation can worsen symptoms. Assessing DBS effects during office visits is challenging, as clinical changes can be delayed hours to days. OBJECTIVES: We evaluated whether local field potentials (LFPs) could serve as an acute biomarker of excessive stimulation in dystonia patients. METHODS: Real-time LFP band power and dystonia severity were quantified and compared during sequential changes in stimulation amplitude. RESULTS: Dystonia worsening was temporally associated with clinically evident and statistically significant increases in LFP band power during in-office DBS programming sessions. CONCLUSIONS: Although increased LFP band power correlated with clear clinical worsening in these patients, we anticipate that not all patients with dystonia will have such immediate signs of worsening. Increased LFP band power during incremented stimulation amplitude may represent a biomarker for patients at-risk of manifesting delayed clinical worsening.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study and its authors were funded by the Phoenix Children's Innovation Circle and the National Institutes of Health
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of Phoenix Children's gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.